A glucagon receptor, upon binding with the signaling molecule glucagon, initiates a signal transduction pathway that begins with the activation of adenylate cyclase, which in turn produces cyclic AMP (cAMP). Protein kinase A, whose activation is dependent on the increased levels of cAMP, is responsible for the ensuing cellular response in the form of protein kinase 1 and 2. The ligand-bound glucagon receptor can also initiate a concurrent signaling pathway that is independent of cAMP by activating phospholipase C. Phospholipase C produces DAG and IP3 from PIP2, a phospholipid phospholipase C cleaves off of the plasma membrane. Ca2+ stores inside the cell release Ca2+ when its calcium channels are bound by IP3.[5][6]
Structure
glucagon/glucagon receptor (blue) with glucagon bound (pink)
The 3D crystallographic structures of the seven transmembrane helical domain (7TM)[7] and the extracellular domain (ECD)[8] and an electron microscopy (EM) map of full length glucagon receptor[9] have been determined. Furthermore, the structural dynamics of an active state complex of the Glucagon receptor, Glucagon, the Receptor activity-modifying protein, and the G-protein C-terminus has been determined using a computational and experimental approach.[10]
↑ Brubaker PL, Drucker DJ (2002). "Structure-function of the glucagon receptor family of G protein-coupled receptors: the glucagon, GIP, GLP-1, and GLP-2 receptors". Receptors & Channels. 8 (3–4): 179–188. doi:10.1080/10606820213687. PMID12529935.
↑ Hager J, Hansen L, Vaisse C, Vionnet N, Philippi A, Poller W, etal. (March 1995). "A missense mutation in the glucagon receptor gene is associated with non-insulin-dependent diabetes mellitus". Nature Genetics. 9 (3): 299–304. doi:10.1038/ng0395-299. PMID7773293. S2CID26951878.
Levey GS, Weiss SR, Ruiz E (April 1975). "Characterization of the glucagon receptor in a pheochromocytoma". The Journal of Clinical Endocrinology and Metabolism. 40 (4): 720–723. doi:10.1210/jcem-40-4-720. PMID165216.
MacNeil DJ, Occi JL, Hey PJ, Strader CD, Graziano MP (January 1994). "Cloning and expression of a human glucagon receptor". Biochemical and Biophysical Research Communications. 198 (1): 328–334. doi:10.1006/bbrc.1994.1046. PMID7507321.
Unson CG, Macdonald D, Merrifield RB (February 1993). "The role of histidine-1 in glucagon action". Archives of Biochemistry and Biophysics. 300 (2): 747–750. doi:10.1006/abbi.1993.1103. PMID8382034.
Yamato E, Ikegami H, Takekawa K, Fujisawa T, Nakagawa Y, Hamada Y, etal. (February 1997). "Tissue-specific and glucose-dependent expression of receptor genes for glucagon and glucagon-like peptide-1 (GLP-1)". Hormone and Metabolic Research. 29 (2): 56–59. doi:10.1055/s-2007-978985. PMID9105899. S2CID42132824.
Strazzullo P, Iacone R, Siani A, Barba G, Russo O, Russo P, etal. (October 2001). "Altered renal sodium handling and hypertension in men carrying the glucagon receptor gene (Gly40Ser) variant". Journal of Molecular Medicine. 79 (10): 574–580. doi:10.1007/s001090100257. PMID11692154. S2CID13804236.
Shiota D, Kasamatsu T, Dib SA, Chacra AR, Moisés RS (May 2002). "Role of the Gly40Ser mutation in the glucagon receptor gene in Brazilian patients with type 2 diabetes mellitus". Pancreas. 24 (4): 386–390. doi:10.1097/00006676-200205000-00010. PMID11961492. S2CID36317323.
Hassel S, Eichner A, Yakymovych M, Hellman U, Knaus P, Souchelnytskyi S (May 2004). "Proteins associated with type II bone morphogenetic protein receptor (BMPR-II) and identified by two-dimensional gel electrophoresis and mass spectrometry". Proteomics. 4 (5): 1346–1358. doi:10.1002/pmic.200300770. PMID15188402. S2CID6773754.
Mortensen OH, Dichmann DS, Abrahamsen N, Grunnet N, Nishimura E (May 2007). "Identification of a novel human glucagon receptor promoter: regulation by cAMP and PGC-1alpha". Gene. 393 (1–2): 127–136. doi:10.1016/j.gene.2007.01.023. PMID17374560.
This page is based on this Wikipedia article Text is available under the CC BY-SA 4.0 license; additional terms may apply. Images, videos and audio are available under their respective licenses.